Nancy E. Denyes
2019
In 2019, Nancy E. Denyes earned a total compensation of $449.3K as General Counsel at aTYR PHARMA.
Compensation breakdown
| Non-Equity Incentive Plan | $49,831 |
|---|---|
| Option Awards | $51,500 |
| Salary | $335,000 |
| Other | $12,932 |
| Total | $449,263 |
Denyes received $335K in salary, accounting for 75% of the total pay in 2019.
Denyes also received $49.8K in non-equity incentive plan, $51.5K in option awards and $12.9K in other compensation.
Rankings
In 2019, Nancy E. Denyes' compensation ranked 12,052nd out of 13,971 executives tracked by ExecPay. In other words, Denyes earned more than 13.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,052 out of 13,971 | 14th |
Division Manufacturing | 4,885 out of 5,701 | 14th |
Major group Chemicals And Allied Products | 1,926 out of 2,200 | 13th |
Industry group Drugs | 1,660 out of 1,886 | 12th |
Industry Biological Products, Except Diagnostic Substances | 358 out of 389 | 8th |
Source: SEC filing on April 2, 2020.
Denyes' colleagues
We found two more compensation records of executives who worked with Nancy E. Denyes at aTYR PHARMA in 2019.